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Endoscopic retrograde cholangiopancreatography (ERCP) offers an effective interventional
option for treating symptomatic chronic pancreatitis. Endoscopic pancreatic sphincterotomy is
performed to facilitated endoscopic treatment. Pancreatic duct strictures can be treated by
inserting plastic stents, and a 10 Fr endoprosthesis is adequate in many cases. Before stent
insertion, hydrostatic balloon dilation is needed in some cases. Pancreatic stones can be
removed with a dormia basket, but combining ERCP and extracorporeal shockwave lithotripsy
(ESWL) is often most effective.
Standard and advanced endoscopic treatment approaches are delineated in this article and
include stricture dilation with a Soehendra retriever, cSEMS placement and multi-stenting.
& 2014 The Author. Published by Elsevier GmbH. This is an open access article under the CC
BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).Video related to this article
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frankfurt.de1. Backgroundpen aChronic pancreatitis is a chronic-inﬂammatory disease
that induces ﬁbrotic changes in the pancreas, often
manifests in recurrent bouts of painful exacerbations,
and in many cases has a exogen-toxic etiology The disease shortens the life expectancy and it most
commonly manifests in men aged 20–40. Characteristic complications of chronic pancreatitis
include the following and might be treated endosco-
pically as indicated (n):
▪ chronic pain (n)
▪ pseudocysts (n)
▪ stenosis of the pancreatic duct (n)ccess article under the CC BY-NC-SA license
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J. Albert62▪ compression of the common bile duct (nn)
▪ duodenal stenosis (?)
▪ vascular complications (–)
▪ malnutrition (–)ble
mb
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mb
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mbFrom these, recurring bouts of pain are the symptoms
that most severely afﬂicts the patient. Endoscopic
treatment aims at relieving pain without causing
harm to the pancreas.1 Evaluation criteria for various diagnostic techniques a
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pancreatic head and/or in calciﬁcations obstructing
the main pancreatic duct, can successfully be
approached by ERP. In case of failure to respond to endoscopic therapy
other cause of the symptoms are probable. Alternative treatment options include surgical resec-
tion techniques and drainage procedures such asing to the Cambridge classiﬁcation.
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wave lithotripsy for calciﬁcations, and Endoscopic ultra-
sound‐guided celiac plexus block. Pseudocysts are endoscopically treated by a trans-
papillary or trans-mural drainage.2. Materials Endoscope: Therapeutic video duodenoscope (e.g., outer
diameter: 11.3 mm, working channel: 4.2 mm, TJF-
Q180V; Olympus EMEA, Hamburg, Germany). Plastic stents for pancreatic stricture, e.g. 7 or 10 Fr
pancreatic stent (Optimed medical Ettlingen; http://
www.opti-med.de/), Germany:; or: 10 Fr pancreatic
stents (MTW, Wesel, Germany); Pusher: 10 Fr, 170 cm
(MTW, Wesel, Germany). Guidewire (0.025″, 270 cm, Visiglide with hydrophilic-
coated tip; Olympus endotherapy, Olympus, Hamburg,
Germany). Catheter (7 Fr, 1.8–2.3 mm, 215 cm; MTW, Wesel,
Germany). cSEMS for pancreatic stricture: Covered self-expanding
metal stent, e.g. TaeWoong medical, BK0807CW
(‘bumpy’, 8 mm diameter, 7 cm length). Balloon dilation catheter for treatment of pancreatic
stricture: Boston maXForce ttS™ (Boston scientiﬁc,
Natick, MA, USA). Soehendras Stent Retrievers for second line treatment
of pancreatic stricture: for 7 Fr stent (SSR-7), 8.5 Fr
stent (SSR-8.5) or 10 Fr stent (SSR-10) (Cook medical,
Bloomington, Indiana 47402 USA).
3. Endoscopic procedure ERP is effective in treatment of main pancreatic duct
strictures at the pancreatic head. Strictures in the pancrea-
tic tail are usually not amenable to endoscopic treatment. ERP is frequently combined with ESWL in treating
pancreatic calciﬁcations and stones. Complications from
endoscopic therapy, e.g. impaction of a basket at
attempting stone removal or duct rupture, are best
prevented by careful selection of patients. Multiple stenting might be an alternative to insertion of a
single 10 Fr plastic stent, which is considered the ﬁrst-
line treatment option by many gastroenterologists. Fully covered metal stents (cSEMS) are an option for non-
operative cases and recurring or refractory strictures.
4. Discussion
In chronic pancreatitis (cP), healthy parenchyma is replaced
by ﬁbrotic tissue due to chronic-recurrent inﬂammation.
Even if the most common classiﬁcation of pathologic
morphology of cP, i.e. the Cambridge classiﬁcation (Table 1),
is originally based on ERP ﬁndings, ERCP is rarely performed
for diagnostic purpose in cP.Therapeutic ERP is used to relief the patient from
symptomatic, painful cP. The intervention aims to alleviate
the outﬂow obstruction to exocrine juice ﬂow. This pre-
sumes that the obstruction (stenosis or stone) is the cause of
the patient's symptoms. In case of failure to respond to
endoscopic therapy other cause of the symptoms are
probable. Pain relief can be achieved by endoscopic tech-
niques in about two thirds of cases. Surgery is more likely to
bring long-term relief compared to endoscopic techniques,
but is associated with higher morbidity and mortality for
pancreatic resection, and endoscopy usually does not
impede later surgery [1-4].
For endoscopic intubation of the pancreatic duct the endo-
scope is placed in the short position with the papilla located in
front. A normal cannula is then advanced at the 1–4 o'clock
position of the native major papilla, but more to the 5 o'clock
position of a papilla with prior biliary sphincterotomy. Minor
papilla cannulation, when indicated, is typically achieved with
the endoscope in the long position using a small catheter with a
0.018″ to 0.025″ guide wire. In case of an failed attempt,
secretin may be administered intravenously to promote pan-
creatic juice ﬂow; alternatively ﬂushing methylene blue over
the papilla may help to delineate the papillary oriﬁces.
Endoscopic pancreatic sphincterotomy is the ﬁrst treatment
approach in all patients and facilitates later endoscopic treat-
ment but has a low rate of long-term relief if not additional
endoscopic techniques are applied. Balloon dilation of the
stricture and stent-insertion, e.g. 10 Fr plastic endoprosthesis
are the mainstay of endoscopic therapy. Plastic stents are left
in place for about one year in most centers. Pancreatic stenting
is successful in 85–98% of cases and pain relief is immediate in
most patients. During a follow-up of more than one year pain-
free patients are observed in 32% to 68%.
Diameter of the plastic stent determines period of stent
patency with larger stents (e.g. 10 Fr) occluding after 2–3
months, and smaller stents occluding earlier. Multiple
plastic stent insertion is reported in one study, and might
be advisable in some cases [4].
Pancreatic pseudocysts are a sequel of acute pancreati-
tis, pancreatic trauma or chronic pancreatitis in 20–40% of
cases. In symptomatic pseudocysts, i.e. infection or symp-
tomatic displacement of adjacent organs, transpapillary or
transmural endoscopic therapy may be considered the ﬁrst-
choice treatment. The transpapillary route by way of ERP
might be considered ﬁrst, and might be more effective in
small pancreatic cysts, but is feasible in only about 50% of
cases. In case of lack of communication of the pancreatic
duct system with the cyst, transmural drainage is needed.
Other techniques for pain relief included endoscopic
ultrasound-guided celiac plexus block. The ESGE considers
EUS-guided celiac block as a second line treatment for
pancreatic pain in cP.
Chronic pancreatitis-related biliary strictures are not
discussed in this article.5. Tips and tricks In a few cases, the pancreatic stricture might be as tight
that hydrostatic balloon dilation does not succeed.
The Soehendra stent retriever might be an alternative
in these cases by ‘screwing’ the device through the
J. Albert64stricture. A secure guidance by a (long) guide-wire is
necessary to avoid damage to the pancreatic duct in this
procedure. For cSEMS use, a diameter of 8 mm is adequate in most
cases, and a diameter of 10 mm might not be tolerated
by at least some patients. Non-covered SEMS are contra-
indicated in chronic pancreatitis.
6. Scripted voiceover
Voiceover Text
Outﬂow obstruction in chronic pancreatitis is amenable
to endoscopic therapy: This overview highlights ERP in
treatment of stenosis of the pancreatic duct or pancreatic
calciﬁcations.
For endoscopic intubation of the pancreatic duct the
endoscope is placed in the short position with the papilla
located in front.
Endoscopic sphincterotomy enables further endoscopic
treatment.
Minor papilla cannulation is achieved with the endoscope
in the long position.
In this ﬁrst case, endoscopic therapy was offered for
symptomatic pancreatic duct stricture of the pancreatic
head and multiple intraductal calciﬁcations.
Ballon dilation of the stricture had been performed to
allow removal of the stones by use of a dormia basket.
Mutiple 7 Fr stents are inserted consecutively for perma-
nent dilation of the ductal stricture.
Plastic stents are placed side by side to improve dilation
effect of stenting.
A pancreatic stricture in the pancreatic head recurred
despite one year of treatment with multiple parallel plastic
stents.
Successful treatment with a fully covered self-expanding
metal stent was performed.
A large intraductal stone obstructs the main pancreatic
duct in a 54 year old male patient; it is situated before a
tight main pancreatic duct stricture.
Of note, this patient has a rare union of the cystic to the
right hepatic duct.
Hydrostatic balloon dilation does not open the stricture.
Stent insertion failed.
A Soehendra retriever is applied; with clockwise turning
the device it is advanced through the stricture.A plastic endoprosthesis can ﬁnally be placed over the
stricture.
Prevertebral calciﬁcation resulted from abdominal
trauma in a 40 year old male.
Repeatedly recurring abdominal pain was due to com-
pression of the main pancreatic duct from the calciﬁcation.
Insertion of a endoprosthesis let the pain immediately
disappear.
ESWL was applied in and the stone completely
fragmented.
ERP is a effective therapeutic option for treatmentof
main pancreatic duct strictures of the pancreatic head.
Plastic stents or fully-covered self expanding metal stents
may be used, and ERP is frequently combined with ESWL for
pancreatic calciﬁcations.Conﬂict of interest
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